GSK’s fair value estimate has seen a modest increase, rising from $16.63 to $17.36 per share. The discount rate remains ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK has announced the purchase of 320,000 of its own ordinary shares as part of its ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

The FTSE 100 opened higher on Wednesday, lifted by strength in miners, upbeat corporate results from GSK and Next, and rising ...

OPEN The FTSE 100 was expected to open 6.1 points higher ahead of the bell on Friday after wrapping up the previous session 0.67% stronger at 9,578.57.

British pharmaceutical group GSK on Wednesday raised its full-year outlook after strong sales growth in its third quarter, ...

GSK and Smith & Nephew outperformed forecast-beating Barclays today as the FTSE 100 index stayed within reach of a 13th consecutive improvement. London’s top flight stood 5.10 points lower at 8458.36, ...

British pharmaceutical giant GSK on Monday said longtime chief executive Emma Walmsley will be replaced by its chief ...

LONDON (Reuters Breakingviews) - GlaxoSmithKline is making a play for the premium aisle of consumer health. The maker of Lemsip drinks and Advil painkillers rejected Unilever’s 50 billion pound offer ...

GlaxoSmithKline had big growth plans for 2020 across its brands—and then the COVID-19 pandemic hit. So the company scrambled to rethink and prioritize “ruthlessly” to find a new way forward. That ...

LONDON, Jan 19 (Reuters Breakingviews) - GlaxoSmithKline (GSK.L), opens new tab is making a play for the premium aisle of consumer health. The maker of Lemsip drinks and Advil painkillers rejected ...